Impact of Fluoropyrimidine and Oxaliplatin-based Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

Background/Aim: To evaluate the benefits of the addition of oxaliplatin (OX) to fluoropyrimidine (FP)-based neoadjuvant chemoradiotherapy (CRT) for patients with locally advanced rectal cancers (LARCs). Patients and Methods: We performed retrospective analyses comparing the pathological complete res...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:In Vivo
Autors principals: OKADA, YUKA, OZAWA, TSUYOSHI, HAYAMA, TAMURO, OHNO, KOHEI, TSUKAMOTO, MITSUO, FUKUSHIMA, YOSHIHISA, SHIMADA, RYU, NOZAWA, KEIJIRO, MATSUDA, KEIJI, HASHIGUCHI, YOJIRO
Format: Artigo
Idioma:Inglês
Publicat: International Institute of Anticancer Research 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880724/
https://ncbi.nlm.nih.gov/pubmed/33402514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12296
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars